AI automated grid placement in the OMERACT knee inflammation MRI scoring system (KIMRISS) for bone marrow lesion

Steel M McDonald1, Stephanie Wichuk1, Rory Gilliland1

  • 1Department of Radiology & Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada.

Abstract

Insights

AI-automated grid placement for bone marrow lesion (BML) scoring in Knee Inflammation MRI Scoring System (KIMRISS) is reliable and feasible. This method enhances the ease and reproducibility of osteoarthritis quantification in clinical trials.

Area of Science:

  • Radiology and Medical Imaging
  • Artificial Intelligence in Medicine
  • Rheumatology and Osteoarthritis Research

Background:

  • Accurate quantification of bone marrow lesions (BMLs) is crucial for assessing osteoarthritis progression.
  • The Knee Inflammation MRI Scoring System (KIMRISS) is a standardized method for BML scoring.
  • Manual grid placement in KIMRISS can be time-consuming and subject to inter-reader variability.

Purpose of the Study:

  • To validate the reliability and feasibility of an AI-automated grid placement method for BML scoring within the KIMRISS framework.
  • To assess the performance of automated grid placement against expert manual placement using the OMERACT Filter criteria.
  • To evaluate the usability and efficiency of the AI-automated system.

Main Methods:

  • Eleven musculoskeletal radiology experts evaluated 40 MRI datasets.
  • Manual and AI-automated grid placements were compared using spatial similarity metrics (Dice Coefficient) and agreement metrics (intraclass correlation coefficients).
  • Feasibility was assessed using the System Usability Scale (SUS).

Main Results:

  • Automated and manual grids showed strong spatial similarity (mean femur Dice Coefficient = 0.78).
  • High agreement was observed between KIMRISS BML scores derived from automated and manual grids (mean ICCs of 0.86 and 0.89 for baseline and change scores).
  • The AI system achieved moderate usability scores (mean SUS = 66.1).

Conclusions:

  • AI-automated grid placement is a reliable and feasible enhancement to the KIMRISS.
  • This automated approach has the potential to improve the ease and reproducibility of BML quantification in osteoarthritis research and clinical trials.
  • The findings support the integration of AI tools to streamline MRI-based osteoarthritis assessment.

Related Concept Videos

Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Radiological Investigation II: MRI and Ventilation Perfusion Scan01:30

Radiological Investigation II: MRI and Ventilation Perfusion Scan

Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...